Renaissance Technologies - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 1 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$431
-47.8%
139,374
-24.0%
0.00%0.0%
Q2 2023$825
+4.6%
183,300
+32.3%
0.00%0.0%
Q1 2023$789
-4.2%
138,500
+1.5%
0.00%0.0%
Q4 2022$824
-99.9%
136,500
-4.8%
0.00%0.0%
Q3 2022$948,000
+13.1%
143,400
-10.6%
0.00%0.0%
Q2 2022$838,000
+202.5%
160,486
+300.2%
0.00%
Q1 2022$277,000
-82.5%
40,100
-68.5%
0.00%
-100.0%
Q4 2021$1,584,000127,2000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$57,226,2391.12%
Baker Brothers Advisors 10,123,824$57,705,7970.31%
Boxer Capital, LLC 699,047$3,9850.20%
GSA CAPITAL PARTNERS LLP 47,614$2710.03%
DENALI ADVISORS LLC 8,200$46,7400.02%
683 Capital Management, LLC 28,631$163,1970.01%
Virtu Financial LLC 11,201$640.01%
UBS ASSET MANAGEMENT AMERICAS LLC 2,273,894$12,961,1960.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,949$210,6090.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 84,667$482,6020.00%
View complete list of PRELUDE THERAPEUTICS INC shareholders